This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 43475 results found since Jan 2013.
Medical News Today: Migraine with aura may raise stroke risk
People who experience migraine with aura - but not migraine without aura - could face a 27 percent greater risk of stroke, a new study finds.
Source: Health News from Medical News Today - September 28, 2017 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Medical News Today: Migraine breakthrough: New drug halves attacks
In a phase III clinical trial of people with episodic migraine, a drug called erenumab was found to cut the number of monthly migraine days by over half.
Source: Health News from Medical News Today - November 30, 2017 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Medical News Today: What is an intractable migraine?
Learn all about status migrainosus, a migraine that lasts for longer than 3 days, also known as intractable migraine. We look at symptoms and treatment.
Source: Health News from Medical News Today - December 8, 2017 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Treating chronic migraine in CADASIL with calcitonin gene-related peptide receptor antagonism
CGRP receptor monoclonal antibodies may be safe for preventing migraine therapy in those with CADASIL; systematic study of safety and efficacy are needed before this approach to migraine prevention can be recommended.
Source: Neurology Clinical Practice - June 9, 2019 Category: Neurology Authors: Goldstein, E. D., Badi, M. K., Meschia, J. F. Tags: Migraine, All Clinical Neurology, All Cerebrovascular disease/Stroke, CADASIL Case Source Type: research
Medical News Today: Study introduces 'the Big Bang Theory of migraine'
A new study finds a link between migraine and signs of early puberty. The scientists suspect that estrogen plays a key role in how migraine originates.
Source: Health News from Medical News Today - July 22, 2019 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Medical News Today: Ocular migraine: Everything you need to know
People with ocular migraine experience migraine episodes with visual symptoms. These can occur with or without a headache. Learn more in this article.
Source: Health News from Medical News Today - July 23, 2019 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Migraine Risk is Brewing Among Heavy Caffeine Drinkers
A cup of coffee/day keeps migraine away? It can, but before recommending another cup to migraine patients, review findings just published.
Source: ConsultantLive - August 29, 2019 Category: Internal Medicine Authors: Sydney Jennings Tags: Headache and Migraine News Source Type: news
Medical News Today: What are migraine auras?
Migraine auras are sensory symptoms, including visual disturbances and physical sensations, that occur during or before a migraine episode. Learn more here.
Source: Health News from Medical News Today - October 9, 2019 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Rimegepant (Nurtec ODT) for Acute Treatment of Migraine
Date: May 4, 2020
Issue #:
1597Summary:
The FDA has approved an orally disintegrating tablet
(ODT) formulation of rimegepant (Nurtec ODT–
Biohaven), a small-molecule calcitonin gene-related
peptide (CGRP) receptor antagonist ( " gepant " ), for
acute treatment of migraine with or without aura
in adults. Rimegepant is the second oral gepant to
become available in the US; ubrogepant(Ubrelvy),
which is approved for the same indication, was the
first. Four parenteral CGRP antagonists, erenumab(Aimovig), fremanezumab(Ajovy), galcanezumab(Emgality), and eptinezumab(Vyepti), are approved
for prevention of migraine.
Source: The Medical Letter - April 14, 2020 Category: Drugs & Pharmacology Authors: admin Tags: Aimovig Ajovy Emgality eptinezumab erenumab fremanezumab galcanezumab Imitrex Migraine NSAIDs Nurtec ODT rimegepant Sumatriptan Ubrelvy ubrogepant Vyepti Source Type: research
CGRP Inhibitors for Migraine
by Diksha Mohanty, MD, and Steven Lippmann, MD Dr. Mohanty is a Neurology Resident Physician, and Dr. Lippmann is a Psychiatry Emeritus Professor at the University of Louisville School of Medicine in Louisville, Kentucky. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of […]
The post CGRP Inhibitors for Migraine appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - April 1, 2020 Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Neurology Review calcitonin-gene related peptide CGRP inhibitor chronic migraine episodic migraine erenumab gepants headache monoclonal antibody Source Type: research
Migraine Triggers Not As Powerful As We Think
Migraine with aura triggers may not be as powerful as most people think. The finding came from new research published in the journal Neurology, the medical journal of the American Academy of Neurology...
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Migraine triggers: Harnessing the messages of clinical practice
In general neurologic practice, you would have seen a patient with migraine today, who would have described the problem, and almost certainly listed triggers for the attacks. So what happens when triggering is tested systematically, and what can we learn?
Source: Neurology - January 28, 2013 Category: Neurology Authors: Goadsby, P. J., Silberstein, S. D. Tags: Migraine EDITORIALS Source Type: research
How do we fashion better trials for neurostimulator studies in migraine?
Numerous investigators make tremendous and respectable efforts so that well-designed and -executed prospective, double-blind, randomized, controlled trials can determine definitively whether therapies of interest are indeed safe and effective. In this issue of Neurology®, Schoenen et al.1 report the results of such a trial conducted at 5 tertiary headache centers in Belgium. They determined whether migraine attacks can be prevented by trigeminal neurostimulation with a supraorbital transcutaneous stimulator: Cefaly. This stimulation device is fashionably designed and its frame resembles a lightweight tiara or sporty sunglasses.
Source: Neurology - February 18, 2013 Category: Neurology Authors: Asano, E., Goadsby, P. J. Tags: All Headache, Migraine, Clinical trials Randomized controlled (CONSORT agreement), Class III EDITORIALS Source Type: research
Battery-Operated Skin Patch Offers New Option for Migraine Sufferers
Title: Battery-Operated Skin Patch Offers New Option for Migraine SufferersCategory: Health NewsCreated: 3/26/2013 2:35:00 PMLast Editorial Review: 3/27/2013 12:00:00 AM
Source: MedicineNet Migraine General - March 27, 2013 Category: Neurology Source Type: news
Figuring Out Your Migraine Triggers Is Tricky
Title: Figuring Out Your Migraine Triggers Is TrickyCategory: Health NewsCreated: 4/22/2013 2:35:00 PMLast Editorial Review: 4/23/2013 12:00:00 AM
Source: MedicineNet Migraine General - April 23, 2013 Category: Neurology Source Type: news
